$ASRT Believe it, or believe it not....Next 2 years, Ebitda will jump to $190m , Total Debt will come down to 200-300, Cosyntropin will be approved and marketed and an additional Product added..By this year's end, lawsuits will be cleared due general agreement. It will be valued at 11x Ebitda -Debt + Cash = around $1.6b or $33 a Share...this is a 50x bagger from this level on... I didn't believe they could manipulate this one to below $1. But, vice-versa can happen, too as it happened once. Once, balance sheet gets better and Product added, Shortie need to cover bringing this one to above $4-$5 at least. Enough to get attention of those who sold. Enough to get Activists or Gurus to buy with an exit Option as we had before with Starboard... If it does not go bk, and obviously it will not, same procedure as last time....
  • 4